pefloxacin has been researched along with Bacterial Infections, Gram-Positive in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andremont, A; Carbon, C; Massias, L; Montravers, P | 1 |
| Bensoussan, F; Bensoussan, M; Bernard, E; Carsenti-Etesse, H; Dellamonica, P; Durant, J; Mondain, V; Pradier, C | 1 |
| Casali, A; Della Giulia, M; Di Lauro, L; Gionfra, T; Santini, S; Sega, FM; Vici, P | 1 |
| Dvoretskiĭ, LI; Iakovlev, SV; Shakhova, TV; Suvorova, MP | 1 |
| Gupta, SK; Satpathy, G; Saxena, R; Sharma, N; Vajpayee, M; Vajpayee, RB; Verma, B | 1 |
| Andremont, A; Azab, M; Boutan-Laroze, A; Droz, JP; Kattan, J; Ribrag, V | 1 |
| Aoun, M; Bourguignon, AM; Daneau, D; Janssen, M; Meunier, F; Van der Auwera, P; Varthalitis, I | 1 |
6 trial(s) available for pefloxacin and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Bacteremia; Bone Marrow Transplantation; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasms; Pefloxacin; Penicillin V; Regression Analysis; Streptococcal Infections | 1994 |
Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoplasma Infections; Neoplasms; Neutropenia; Pefloxacin; Thienamycins; Vancomycin | 1997 |
[Program of empirical antibacterial therapy of community-acquired pneumonia].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftibuten; Cefuroxime; Cephalosporins; Community-Acquired Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Pefloxacin; Pneumonia, Bacterial; Roxithromycin; Spiramycin | 1998 |
Topical pefloxacin in bacterial keratitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Child; Cornea; Corneal Ulcer; Eye Infections, Bacterial; Female; Follow-Up Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Ophthalmic Solutions; Pefloxacin; Prospective Studies; Safety; Treatment Outcome; Visual Acuity | 1998 |
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Neoplasms; Neutropenia; Pefloxacin; Piperacillin; Vancomycin | 1992 |
A prospective, randomized study of pefloxacin versus teicoplanin in the treatment of gram-positive coccal infections in cancer patients: early termination due to emergence of resistance to fluoroquinolones.
Topics: 4-Quinolones; Adult; Aged; Anti-Infective Agents; Bacteremia; Drug Resistance, Microbial; Drug Tolerance; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Pefloxacin; Pneumonia; Prospective Studies; Quinolones; Staphylococcal Infections; Teicoplanin | 1994 |
2 other study(ies) available for pefloxacin and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1994 |
Effect of subinhibitory concentrations of pefloxacin in infection in mice due to susceptible or resistant strains.
Topics: Animals; Anti-Infective Agents; Catheterization; Drug Resistance, Microbial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Mice; Pefloxacin; Spleen; Staphylococcal Infections | 1995 |